Subtype-specificity of the presynaptic α2-adrenoceptors modulating hippocampal norepinephrine release in rat

作者: J.P. Kiss , G. Zsilla , A. Mike , T. Zelles , E. Toth

DOI: 10.1016/0006-8993(94)01447-P

关键词:

摘要: In vivo brain microdialysis and high-performance liquid chromatography with electrochemical detection were used to study the effect of different selective α2-antagonists on hippocampal norepinephrine (NE) release in freely moving awake rat. Systemic administration (0.5 mg/kg i.p.) either α2AD-antagonist BRL 44408 or α-2BC-antagonist ARC 239 did not significantly change basal NE. At a higher dose (5 was still ineffective, whereas caused significant increase extracellular level Similar results obtained from vitro perfusion experiments. Rat slices loaded [3H]NE electrical stimulation-evoked determined. The applied concentration range 10−8 10−6 M. increased electrically induced [3H]NE. agreement data displaced [3H]yohimbine cortical membranes rat high affinity less effective. pKi values eight α2-adrenergic compounds showed very good correlation (r = 0.98, slope 1.11 P < 0.0001) hippocampus frontal cortex where α2-adrenoceptors have been characterized as α2D-subtype. Our indicate that NE is regulated by α2D-adrenoceptors, species variation human α2A-subtype.

参考文章(43)
D. N. Thomas, R. B. Holman, A microdialysis study of the regulation of endogenous noradrenaline release in the rat hippocampus. Journal of Neurochemistry. ,vol. 56, pp. 1741- 1746 ,(1991) , 10.1111/J.1471-4159.1991.TB02075.X
Karen Smith, James R. Docherty, Are the prejunctional α2-adrenoceptors of the rat vas deferens and submandibular gland of the α2A-orα2D-subtype? European Journal of Pharmacology. ,vol. 219, pp. 203- 210 ,(1992) , 10.1016/0014-2999(92)90297-H
J. W. Lomasney, W. Lorenz, L. F. Allen, K. King, J. W. Regan, T. L. Yang-Feng, M. G. Caron, R. J. Lefkowitz, Expansion of the alpha 2-adrenergic receptor family: cloning and characterization of a human alpha 2-adrenergic receptor subtype, the gene for which is located on chromosome 2. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 5094- 5098 ,(1990) , 10.1073/PNAS.87.13.5094
B. Kobilka, H Matsui, T. Kobilka, T. Yang-Feng, U Francke, M. Caron, R. Lefkowitz, J. Regan, Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor Science. ,vol. 238, pp. 650- 656 ,(1987) , 10.1126/SCIENCE.2823383
Paul Young, John Berge, Helen Chapman, Michael A. Cawthorne, Novel α2-adrenoceptor antagonists show selectivity for α2A- and α2B-adrenoceptor subtypes European Journal of Pharmacology. ,vol. 168, pp. 381- 386 ,(1989) , 10.1016/0014-2999(89)90801-7
J. W. Regan, T. S. Kobilka, T. L. Yang-Feng, M. G. Caron, R. J. Lefkowitz, B. K. Kobilka, Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 6301- 6305 ,(1988) , 10.1073/PNAS.85.17.6301
Anthony P. Nicholas, Vincent Pieribone, Tomas Hökfelt, Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. The Journal of Comparative Neurology. ,vol. 328, pp. 575- 594 ,(1993) , 10.1002/CNE.903280409
A.C. MacKinnon, A.T. Kilpatrick, B.A. Kenny, M. Speeding, C.M. Brown, [3H]-RS-15385-197, a selective and high affinity radioligand for α2-adrenoceptors : implications for receptor classification British Journal of Pharmacology. ,vol. 106, pp. 1011- 1018 ,(1992) , 10.1111/J.1476-5381.1992.TB14449.X
David B. Bylund, Heterogeneity of alpha-2 adrenergic receptors. Pharmacology, Biochemistry and Behavior. ,vol. 22, pp. 835- 843 ,(1985) , 10.1016/0091-3057(85)90536-2